Site Search

Search
Cystic Fibrosis Foundation Therapeutics (CFFT) | Genetics
Gene Editing: Q&A With Bill Skach

Cystic Fibrosis Foundation Therapeutics Inc. made its first major award last month to advance gene editing research in cystic fibrosis. Editas Medicine Inc. will explore the potential of using what some scientists refer to as “a tiny pair of scissors” to snip out the genetic defect that causes CF.

Susan-Schept-headshot
Susan Schept
| 6 min read
Our Research Approach | Genetics
Video Explains How Gene Editing Could Be Used for CF

The Cystic Fibrosis Foundation is funding research into gene editing techniques to see if they can be used to fix the mutations that cause cystic fibrosis. One of the most popular techniques is CRISPR-Cas9. To see how this might work for CF, watch this video. 

Susan-Schept-headshot
Susan Schept
| 2 min read
Genetics | Intro to CF
Role of Genetics in CF
About 30,000 people in the U.S. have cystic fibrosis, a rare genetic disease. The majority of people with CF are diagnosed by age 2 thanks to newborn screening tests. If you have CF or are considering testing for it, knowing about the role of genetics in CF can help you make decisions about your health care.